Investigating a new target for cancer treatment
Targeting a Novel Pocket on ITGAV
This study is exploring new ways to treat leukemia and solid tumors by looking at a protein called Integrin Alpha V, using both computer models and lab tests, to find better treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10930939 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapies for various types of leukemia and solid tumors by targeting a specific protein called Integrin Alpha V (ITGAV). The approach combines advanced mathematical modeling with laboratory experiments to identify effective treatment strategies. Researchers will utilize CRISPR technology to screen and validate the role of ITGAV in cancer cell survival, aiming to uncover new therapeutic options for patients. The project seeks to enhance our understanding of cancer complexities and improve treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute leukemias or advanced solid tumors who are seeking new treatment options.
Not a fit: Patients with non-cancerous conditions or those whose cancers do not involve the targeted pathways may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new, more effective treatments for patients with leukemia and solid tumors.
How similar studies have performed: Previous research has shown promise in targeting integrins for cancer treatment, indicating that this approach may lead to significant advancements in therapy.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Mattson, Nicole — University of California, San Diego
- Study coordinator: Mattson, Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.